Neurology: Volume 94, Number 15, April 14, 2020 Exam #2 - Neuro R2 score: Predicting high-risk neurologic readmissions within 30 days

About this course

Released: 04/15/2020
Expires: 04/15/2023

NEURO R² SCORE: PREDICTING HIGH-RISK NEUROLOGIC READMISSIONS WITHIN 30 DAYS

LEARNING OBJECTIVES:

Upon completion of the article by Peacock et al, the participant should be able to:

Discuss how readmission rates differed following hospitalizations for neurologic conditions and hospitalizations for non-neurologic conditions in this study
Identify which neurologic conditions were associated with the highest risk of readmission in multivariable analyses used in this study
State the degree to which hospital readmission rate increased with increased Neuro R² score in this study

CORE COMPETENCIES:

The article by Peacock et al covers the following core competency:

Medical Knowledge

AUTHOR DISCLOSURES:

Refer to Information and Author section available in the Tool Bar for each article.

THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES

ACCREDITATION STATEMENT

The American Academy of Neurology Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

MISSION STATEMENT/PROGRAM OBJECTIVES

After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.

PARTICIPANTS

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

AMA CREDIT DESIGNATION STATEMENT

The American Academy of Neurology Institute designates this journal-based-CME activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURES

James WM Owens Jr. MD, PhD receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology. Adam Kelly, MD, has served as a guest editor of Continuum (April 2014) and receives a stipend in his editorial capacity for Neurology.

COMMERCIAL SUPPORT

This CME program receives no commercial support.